ABT Abbott Laboratories
$101.29
Abbott Laboratories (ABT) is expected to report earnings on October 19, 2026, before the market open. The consensus earnings estimate is $1.43 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.3% since its last earnings release on July 16, 2026.
Abbott Laboratories Beat Expectations, Raises Earnings Guidance, but Remains In-line with Estimates
Thursday, July 16, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 19
Monday · 7:30 AM ET
Earnings Whisper
-
vs $1.43
Rev est $12.91B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$106.00
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Abbott Laboratories
Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 14 ETFs, by dollar flow
- OEF iShares S&P 100 ETF
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- IOO iShares Global 100 ETF
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
Charts powered in part by Lightweight Charts™ by TradingView.